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G-RC-8
THE IMPACT OF AGING ON CILIARY FUNCTION AND ULTRASTRUCTURE IN HUMAN
RESPIRATORY EPITHELIUM
James CM Ho. WK Lam, W Hu, R Leung, J Sun, KN Chan, LW Chu, KWT Tsang University Department of
Medicine, The University of Hong Kong, Hong Kong SAR
The elderly have increased susceptibility to lower respiratory tract infections which is partly attributed to
concomitant respiratory diseases, gastro-oesophageal reflux, swallowing difficulties, and immobility. Although
mucociliary clearance plays a crucial role in the defence against inhaled microbes, little is known on the effect
of aging on respiratory ciliary function and ultrastructure. We have studied the ciliary beat frequency and
ultrastructure of respiratory cilia on 100 volunteers (53 males; mean ± S.D. age 52.1 ±24 yrs; range 11-90 yrs).
Respiratory cilia were obtained from the inferior turbinate for measurement of ciliary beat frequency using an
established photometric method. The mean ± S.D. ciliary beat frequency were 12.9+ 1.7 Hz (range 9.1-17).
Transmission electron microscopy (TEM) examination was performed on ultrathin sections using a morphometric
protocol on all subjects. TEM examination revealed a significant increase in the frequency of microtubular
disarrangement and presence of single tubules with aging (p=0.002 and 0.005 respectively). The mean SD
derived from the angles formed between the central microtubules of neighboring cilia was 12.4° (± 3.7°).
Ciliary beat frequency negatively correlate with age (r=-0.45, p<0.001) but bore no gender difference (p>0.05).
Our finding of impaired ciliary function and the increased frequency of ciliary ultrastructural anomalies with
aging could help explain the frequent occurrence of respiratory infections in the elderly.
G-RC-9
CHEMORADIOTHERAPY IN ADVANCED LYMPHOEPITHELIOMA-LIKE CARCINOMA (LELC)
OF LUNG
James CM Ho. WK Lam, +GC Ooi, *MP Wong, B Lam, KWT Tsang University Departments of Medicine,
+Diagnostic Radiology, and 'Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong
SAR, China
Lymphoepithelioma-like carcinoma (LELC) of the lung, an Epstein-Barr virus (EBV)-associated undifferentiated
carcinoma, is a rare entity of pulmonary malignancy. It appears to show predilection for young non-smoking
Asians and is often resectable. However, little is known on the treatment of the even rarer locally advanced or
metastatic cases. We have conducted a prospective study on the use of combination chemotherapy (5-fluorouracil,
leucovorin, and cisplatin) and radiotherapy in the treatment of locally advanced or metastatic LELC of lung.
The inclusion criteria included age between 18 and 70 years, good performance state (WHO 0 or 1), histologically
proven stage III or IV unresectable tumours, chemotherapy or radiotherapy naive, and nasopharyngeal carcinoma
ruled out by endoscopic biopsy and magnetic resonance imaging, Exclusion criteria included previous
malignancies, major organ failure and active uncontrolled infections. In-situ hybridization (ISH) for EBV-
encoded small nuclear RNA (EBER) was performed on the biopsy specimens. Serological tests for EBV viral
capsid antigen were serially performed during chemotherapy. Chemotherapy constituted four 4-weekly cycles
of 5-fluorouracil (5-FU, 1000mg/m2/day on day 1 to 4), leucovorin (200mg/m2 on day 1 to 4), and cisplatin
(100mg/m2 on day 1). Sequential local radiotherapy to mediastinum, given as 16x 2.5Gy/fraction, was included
for locally advanced disease. Three cases (two females, mean age 42 years) of lung LELC were recruited
between July 98 to June 99. Serum IgA titres to EBV were raised to the upper limit of detection of our
laboratory at >1/640 in all three cases. These remained at the same level throughout the course of chemotherapy.
Two of the patients had adequate biopsy specimens for detection of EBER which were positive. The tumour
response rate to chemotherapy was 67% (2/3) partial response and 33% (1/3) stable disease. The latter was
given local radiotherapy with partial response. Severe toxicities (NCI grade 3 or 4) included grade 3 vomiting
(1 case) and grade 3 stomatitis (1 case). Our experience with the chemoradiotherapy helps in better understanding
of the combined modality treatment in advanced or metastatic LELC of lung. This warrants future research in
the treatment of this rather chemoradiosensitive malignancy.
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